| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/22/2006 | EP1451368A4 Single nucleotide polymorphisms in gh-1 |
| 02/22/2006 | EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2006 | EP1296706B1 Osteoclast secreted chemokine and uses thereof |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1244803B1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 02/22/2006 | EP1212464B1 Diagnostics and therapeutics for osteoporosis |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1040185B1 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0907378B1 Method for the concentration of antibody solutions |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | EP0656060B1 Androgen regulation with dna sequences of rat probasin gene |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738896A Composition and method for treating lupus nephritis |
| 02/22/2006 | CN1738832A Ligands |
| 02/22/2006 | CN1738830A 培哚普利 Perindopril |
| 02/22/2006 | CN1738644A Gastrin compositions and methods of use and preparation |
| 02/22/2006 | CN1738641A Pharmacological vitreolysis |
| 02/22/2006 | CN1738640A Interferon-alpha polypeptides and conjugates |
| 02/22/2006 | CN1738639A Hcv联合疗法 Hcv combination therapy |
| 02/22/2006 | CN1738638A Medicinal composition for treating ischemic cardiac failure |
| 02/22/2006 | CN1738637A DC-SIGN blockers and their use for preventing or treating viral infections. |
| 02/22/2006 | CN1738636A Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases wit |
| 02/22/2006 | CN1738635A Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 02/22/2006 | CN1738631A Topical composition and methods for treatment of aged or environmentally damaged skin |
| 02/22/2006 | CN1738627A Method for inhibition of necrosis induced by neurotrophin |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1738606A Improved oral delivery of peptides |
| 02/22/2006 | CN1738602A Formulations for the rectal administration of thrombolytically-active agents |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1737147A Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein ú¿HSP65-HBcAgú® |
| 02/22/2006 | CN1737139A Prostate disease related gene and its coding polypeptide and its uses |
| 02/22/2006 | CN1737134A High purity kallidinogenase prepartion method and its pharmaceutical formulation |
| 02/22/2006 | CN1737133A High purity venom fibrinolysin prepartion method and its pharmaceutical formulation |
| 02/22/2006 | CN1737012A Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 02/22/2006 | CN1737009A Polypeptide compound and its medicinal uses |
| 02/22/2006 | CN1736478A Composition for lowering blood fat |
| 02/22/2006 | CN1736477A Application of combination of cytokine and hypoglycemic in treatment of diabetes |
| 02/22/2006 | CN1736476A Transfer factor powder spray and preparation process thereof |
| 02/22/2006 | CN1736475A Troxerutin brain protein hydrolysate for injection and preparation process thereof |
| 02/22/2006 | CN1736366A Preparation process and application of inorganic salt nanometer particle containing biological active material and enveloped Chinese medicinal ingredient |
| 02/22/2006 | CN1736338A Apparatus for diagnosing and treating allergic disease |
| 02/22/2006 | CN1243093C Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243020C Application of cardiokinetic hormone in liver disease |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1243014C Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 02/22/2006 | CN1243013C Adherence peptide specific to tissue of liver cancer, in vivo and in vitro combined screen method, and usage |
| 02/22/2006 | CN1242814C Protease inhibitor of Ornithotoctonus huwena |
| 02/22/2006 | CN1242813C Combination therapy for osteoporosis |
| 02/22/2006 | CN1242812C Gelling agent of stimulating factor of macrophage colony of recombined human granular leudocytes and preparation method |
| 02/22/2006 | CN1242811C New use of recombinant hirudin |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/21/2006 | US7002027 Drug delivery enhancing agents with cholic acid and monosaccharide groups for treating cancer by gene therapy; tissue or organs having an epithelial membrane |
| 02/21/2006 | US7002003 oligonucleotide with optimal nucleotide binding sites for transcription factor; signal trandsducers and activators of transcription (STAT); treating cancer |
| 02/21/2006 | US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 02/21/2006 | US7002000 Nucleic acid encoding α chain of human IL-11 receptor |
| 02/21/2006 | US7001998 Nucleic acids encoding a chimeric glycosyltransferase |
| 02/21/2006 | US7001997 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001992 Antibodies to secreted protein HEMCM42 |
| 02/21/2006 | US7001991 transferrin-doxorubicin linked with glutaraldehyde; low-toxicity, side-effect reduction |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001987 Hydrogel with controllable mechanical, chemical, and biological properties and method for making same |
| 02/21/2006 | US7001984 Oligopeptides which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using compounds for |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001980 Monoclonal antibodies directed against the G3BP protein, and uses |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | US7001891 Biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/21/2006 | US7001886 Hot melt method for preparing diphenhydramine tannate |
| 02/21/2006 | US7001885 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer |
| 02/21/2006 | US7001884 polypeptide with selective amino acid substitutions; nontoxic protease inhibitors; bactericides, fungicides, viricides |
| 02/21/2006 | US7001883 Cyclized conotoxin peptides |
| 02/21/2006 | US7001881 joint-lubricating glycoproteins; polypeptide and O-linked oligosaccharide moiety [B(1-3)Gal-GalNAc]; antiarthritic agent maintains viscosity of synovial fluid; osteoarthritis |
| 02/21/2006 | US7001769 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 02/21/2006 | US7001766 Nucleotide sequences coding polypeptide for use the treatment of hypercholesterolaemia, diabetes, hypercholesterolaemia, hypoglycemia, graves disease, goiter, cushing's, addison, gastrointestinal and autoimmune diseases |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001761 DNA sequences comprising dystrophin minigenes and methods of use thereof |
| 02/21/2006 | US7001753 59079 and 12599, protein kinase family members and uses therefor |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001728 Protein of given amino acid sequence which is the product of a gene which shows enhanced expression due to stimulation with TNF alpha; use drug screening; plays an important role in protein protein interactions; drug target |
| 02/21/2006 | US7001718 Prevent complexing of Dna and ligand; viricides; drug mixture with carrier |
| 02/21/2006 | US7001715 Hemoglobulin blood substitute |
| 02/21/2006 | US7001604 Cosmetic composition |
| 02/21/2006 | US7001602 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001598 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |